1,2,3,4,5,6-Hexahydrobenzo[b]azocine, 97%, 250mg

4-Methyl-6-trifluoromethyl-pyridin-2-ol, 95.0%, 250mg

4,4',4''-(Benzene-1,3,5-triyltris(oxy))tribenzoic acid, 97%, 1g

3-(5-tert-Butyl-1,2,4-oxadiazol-3-yl)piperidine hydrochloride, 1g

4-CHLORO-6-FLUOROINDOLINE-2,3-DIONE, 90.0%, 5g

2-Fluoro-6-(pyrrolidin-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid, 97%, 1g

3-Oxobenzo[d]isothiazole-2(3H)-carbaldehyde 1,1-dioxide, 97%, 10g

2,2,6,6-Tetramethylpiperidin-4-one hydrochloride, 95.0%, 500mg

1,2-Dibromo-4,5-dimethoxybenzene, 98.0%, 5g

6-Chloro-7-deazapurine>98.0%(GC)(T)1g

7-Amino-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 10g

Serological pipettes ROTILABO®, 2 ml, 10 x (100 x 1), 1000 pieces